Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
Ahmad Awada,Agustin A Garcia,Stephen Chan,Guy H M Jerusalem,Robert E Coleman,Manon T Huizing,Aminder Mehdi,Sue M O'Reilly,John T Hamm,Peter J Barrett-Lee,Veronique Cocquyt,Kostandinos Sideras,David E Young,Carol Zhao,Yen Lin Chia,Ute Hoch, et al.
The Lancet Oncology
Copyright © 2013, Elsevier
Welcome to RightsLink
Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.
I would like to...
To request permission for a type of use not listed, please contact Elsevier Global Rights Department.Are you the author of this Elsevier journal article?
Clearance Center, Inc. All Rights Reserved.
Comments? We would like to hear from you. E-mail us at